Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Registries and Trial updates I Pharmacotherapy HFA Premium Access Heart Failure 2022

ESC 365 is supported by

ESC 365 is supported by